LANTHEUS HOLDINGS INC (LNTH)
US5165441032 - Common Stock
We assign a fundamental rating of 7 out of 10 to LNTH. LNTH was compared to 195 industry peers in the Health Care Equipment & Supplies industry. LNTH has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. LNTH is growing strongly while it also seems undervalued. This is an interesting combination With these ratings, LNTH could be worth investigating further for value and growth and quality investing!.
1. Profitability
1.1 Basic Checks
In the past year LNTH was profitable.
In the past year LNTH had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: LNTH reported negative net income in multiple years.
In the past 5 years LNTH always reported a positive cash flow from operatings.
1.2 Ratios
LNTH's Return On Assets of 19.79% is amongst the best of the industry. LNTH outperforms 98.46% of its industry peers.
LNTH has a better Return On Equity (40.04%) than 99.49% of its industry peers.
The Return On Invested Capital of LNTH (26.97%) is better than 99.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 19.79% | ||
| ROE | 40.04% | ||
| ROIC | 26.97% |
ROA(3y)4.55%
ROA(5y)3.98%
ROE(3y)10.32%
ROE(5y)11.2%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 25.20%, LNTH belongs to the best of the industry, outperforming 96.92% of the companies in the same industry.
LNTH's Profit Margin has improved in the last couple of years.
The Operating Margin of LNTH (38.31%) is better than 99.49% of its industry peers.
In the last couple of years the Operating Margin of LNTH has grown nicely.
LNTH has a better Gross Margin (63.71%) than 63.08% of its industry peers.
LNTH's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 38.31% | ||
| PM (TTM) | 25.2% | ||
| GM | 63.71% |
OM growth 3Y69.82%
OM growth 5Y8.97%
PM growth 3YN/A
PM growth 5Y16.4%
GM growth 3Y7.77%
GM growth 5Y1.45%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), LNTH is creating value.
LNTH has less shares outstanding than it did 1 year ago.
The number of shares outstanding for LNTH has been increased compared to 5 years ago.
The debt/assets ratio for LNTH has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 5.72 indicates that LNTH is not in any danger for bankruptcy at the moment.
LNTH's Altman-Z score of 5.72 is amongst the best of the industry. LNTH outperforms 81.54% of its industry peers.
LNTH has a debt to FCF ratio of 2.64. This is a good value and a sign of high solvency as LNTH would need 2.64 years to pay back of all of its debts.
LNTH has a better Debt to FCF ratio (2.64) than 88.72% of its industry peers.
A Debt/Equity ratio of 0.69 indicates that LNTH is somewhat dependend on debt financing.
LNTH has a worse Debt to Equity ratio (0.69) than 72.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 2.64 | ||
| Altman-Z | 5.72 |
ROIC/WACC2.8
WACC9.62%
2.3 Liquidity
LNTH has a Current Ratio of 5.80. This indicates that LNTH is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of LNTH (5.80) is better than 77.95% of its industry peers.
LNTH has a Quick Ratio of 5.45. This indicates that LNTH is financially healthy and has no problem in meeting its short term obligations.
LNTH has a Quick ratio of 5.45. This is in the better half of the industry: LNTH outperforms 79.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.8 | ||
| Quick Ratio | 5.45 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 47.63% over the past year.
The Earnings Per Share has been growing by 45.36% on average over the past years. This is a very strong growth
Looking at the last year, LNTH shows a very strong growth in Revenue. The Revenue has grown by 38.64%.
The Revenue has been growing by 30.43% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)47.63%
EPS 3Y121.92%
EPS 5Y45.36%
EPS growth Q2Q27.74%
Revenue 1Y (TTM)38.64%
Revenue growth 3Y56.32%
Revenue growth 5Y30.43%
Revenue growth Q2Q34.5%
3.2 Future
LNTH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.43% yearly.
LNTH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.10% yearly.
EPS Next Y7.67%
EPS Next 2Y4.48%
EPS Next 3Y7.58%
EPS Next 5Y15.43%
Revenue Next Year11.53%
Revenue Next 2Y9.34%
Revenue Next 3Y11.13%
Revenue Next 5Y10.1%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 10.47, the valuation of LNTH can be described as very reasonable.
LNTH's Price/Earnings ratio is rather cheap when compared to the industry. LNTH is cheaper than 95.90% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.25, LNTH is valued rather cheaply.
With a Price/Forward Earnings ratio of 9.72, the valuation of LNTH can be described as very reasonable.
Based on the Price/Forward Earnings ratio, LNTH is valued cheaper than 96.92% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.67. LNTH is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.47 | ||
| Fwd PE | 9.72 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LNTH indicates a rather cheap valuation: LNTH is cheaper than 96.41% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, LNTH is valued cheaply inside the industry as 91.79% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.95 | ||
| EV/EBITDA | 7.66 |
4.3 Compensation for Growth
LNTH's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
LNTH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.37
PEG (5Y)0.23
EPS Next 2Y4.48%
EPS Next 3Y7.58%
5. Dividend
5.1 Amount
LNTH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
LANTHEUS HOLDINGS INC
NASDAQ:LNTH (4/24/2024, 7:14:28 PM)
After market: 65.21 0 (0%)65.21
+0.8 (+1.24%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.47B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.47 | ||
| Fwd PE | 9.72 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.37
PEG (5Y)0.23
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 19.79% | ||
| ROE | 40.04% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 38.31% | ||
| PM (TTM) | 25.2% | ||
| GM | 63.71% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.79
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 5.8 | ||
| Quick Ratio | 5.45 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)47.63%
EPS 3Y121.92%
EPS 5Y
EPS growth Q2Q
EPS Next Y7.67%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)38.64%
Revenue growth 3Y56.32%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y